랩온어칩용 컴포넌트 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global lab-on-a-chip component market size is expected to reach USD 18.15 Billion in 2034 from USD 7.74 Billion in 2025, growing at a CAGR of 9.93 during 2026-2034.This market is expanding rapidly due to the increasing demand for miniaturized diagnostic and analytical devices in healthcare and research applications. Lab-on-a-chip components enable faster testing, reduced sample consumption, and improved diagnostic accuracy, making them highly valuable in medical diagnostics, biotechnology, and pharmaceutical research. Rising adoption of point-of-care testing technologies is significantly contributing to market growth worldwide.

Technological advancements in microfluidics, biosensors, and nanotechnology are major drivers supporting the development of the industry. Healthcare providers and research laboratories are increasingly utilizing lab-on-a-chip systems for disease detection, drug discovery, and genetic analysis. The growing prevalence of infectious diseases and rising demand for portable diagnostic solutions are further accelerating market expansion across developed and emerging economies.

Future prospects for the market remain highly positive as personalized medicine and digital healthcare continue to evolve globally. Increasing investments in biomedical research and the integration of artificial intelligence into diagnostic platforms are expected to improve testing efficiency and reliability. Expanding healthcare infrastructure and rising demand for rapid diagnostic technologies are likely to create significant long-term growth opportunities for manufacturers and technology providers.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product & Service

• Reagents & Consumables
• Instruments
• Software & Services

By Technology

• Microfluidics Technology
• Optical Technology
• Electrochemical Technology
• Others

By Application

• Clinical Diagnostics
• Drug Discovery & Development
• Others

By End Use

• Academic & Research Institutes
• Hospitals & Diagnostic Centers
• Pharmaceutical & Biotechnology Companies
• Others

COMPANIES PROFILED

• Thermo Fisher Scientific, Inc., Illumina, Inc., Danaher, Merck KGaA, Abbott Laboratories, QIAGEN, Agilent Technologies, Standard BioTools, Revvity, Inc., Bio-Rad Laboratories, F. Hoffmann-La Roche AG, Becton, Dickinson and Company, Fluidigm Corporation, PerkinElmer, IDEX Corporation

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL LAB-ON-A-CHIP COMPONENT MARKET: BY PRODUCT & SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product & Service
• 4.2. Reagents & Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Software & Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL LAB-ON-A-CHIP COMPONENT MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Microfluidics Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Optical Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Electrochemical Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL LAB-ON-A-CHIP COMPONENT MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Clinical Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Drug Discovery & Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL LAB-ON-A-CHIP COMPONENT MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Hospitals & Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL LAB-ON-A-CHIP COMPONENT MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product & Service
  • 8.2.2 By Technology
  • 8.2.3 By Application
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product & Service
  • 8.3.2 By Technology
  • 8.3.3 By Application
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product & Service
  • 8.4.2 By Technology
  • 8.4.3 By Application
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product & Service
  • 8.5.2 By Technology
  • 8.5.3 By Application
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product & Service
  • 8.6.2 By Technology
  • 8.6.3 By Application
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL LAB-ON-A-CHIP COMPONENT INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Thermo Fisher ScientificInc
  • 10.2.2 IlluminaInc
  • 10.2.3 Danaher
  • 10.2.4 Merck KGaA
  • 10.2.5 Abbott Laboratories
  • 10.2.6 QIAGEN
  • 10.2.7 Agilent Technologies
  • 10.2.8 Standard BioTools
  • 10.2.9 RevvityInc
  • 10.2.10 Bio-Rad Laboratories
  • 10.2.11 F. Hoffmann-La Roche AG
  • 10.2.12 Becton, Dickinson And Company
  • 10.2.13 Fluidigm Corporation
  • 10.2.14 PerkinElmer
  • 10.2.15 IDEX Corporation